Anbio Biotechnology (NNNN) Stock Price, Quote, News & History

Key Statistics

Open

$6.58

$6.54

Volume / Avg.

231.15K / 97.33K

Day Range

$6.36 - $6.77

52 Wk Range

6.28 - 51.33

Market Cap

$285.29M

P/E Ratio

44.29

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.06%

Days to Cover

Recent Anbio Biotechnology News

Why JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

JOYY Inc (NASDAQ: JOYY) reported Q2 earnings below estimates, but beat revenue expectations. Shares rise 3.6% in pre-market trading.

Avi Kapoor

H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday

H World Group (HTHT) beats earnings and raises sales guidance, shares jump 8.1%. Other big gainers include ANGX, ARGX, and MESO.

Avi Kapoor

Top 3 Health Care Stocks That May Rocket Higher In July

Health care sector oversold - buying opportunities in undervalued companies. RSI compares stock strength on up/down days, below 30 is oversold.

Avi Kapoor

Top 3 Health Care Stocks That May Rocket Higher In July

Oversold health care stocks: EVMN, NNNN, NAUT. RSI <30 shows they may be undervalued. EVMN dropped 46% due to trial failure. NNNN & NAUT had 17% & 12% drops.

Avi Kapoor

Top 3 Health Care Stocks You'll Regret Missing In Q2

Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold, according to Benzinga Pro. iRhythm, Procept Biorobotics, Anbio Biotechnology among lowest RSI values.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-6.74M

Investing Cash Flow (TTM)

-4.20M

Financing Cash Flow (TTM)

6.95M

Free Cash Flow (TTM)

-6.74M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-3.99M

Valuation Metrics

Enterprise Value

$269.44M

PE Ratio (TTM)

44.29

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

32.88

PB Ratio (TTM)

9.48

Earnings Yield % (TTM)

2.26%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

47.48

Price / EBITDA (TTM)

49.29

Price / Free Cash Flow (TTM)

Book Value / Share

$0.69

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$7.77M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$6.58

$6.54

Volume / Avg.

231.15K / 97.33K

Day Range

$6.36 - $6.77

52 Wk Range

6.28 - 51.33

Market Cap

$285.29M

P/E Ratio

44.29

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.06%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient pr...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

NNNN

ABBV

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

NNNN

ABBV

FAQ

How do I buy Anbio Biotechnology (NNNN) stock?

You can purchase shares of Anbio Biotechnology (NASDAQ:NNNN) through any online brokerage.

View our list of the best stock brokerages

Who are Anbio Biotechnology (NNNN) competitors?

Other companies in Anbio Biotechnology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for Anbio Biotechnology (NNNN) stock?

There is no analysis for Anbio Biotechnology to provide a consensus price target.

What is the current price for Anbio Biotechnology (NNNN)?

The stock price for Anbio Biotechnology (NASDAQ: NNNN) is $6.5 last updated September 4, 2026 at 8:25 AM EDT.

Does Anbio Biotechnology (NNNN) pay a dividend?

There are no upcoming dividends for Anbio Biotechnology.

When is Anbio Biotechnology (NASDAQ:NNNN) reporting earnings?

Anbio Biotechnology does not have any upcoming earnings scheduled.

Is Anbio Biotechnology (NNNN) going to split?

There is no upcoming split for Anbio Biotechnology.

What sector and industry does Anbio Biotechnology (NNNN) operate in?

Anbio Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.